What changed
$SNX — AVOID 📊 | 6 MONTHS THESIS
🧭 Conviction: HIGH
🎯 FQ2 FY2026 (ends May) | reported Jun 25 | Rev $17.2B | EPS $4.70 vs $3.92 🟢 | Margin 2.9%
💡 The EPS beat shows consensus underestimated earnings, but the stock may already reflect this. The deeper gap is the market's extreme pessimism on FCF (-11.5% growth implied). If FCF merely stabilizes, the stock could rerate upward, but this is uncertain and not yet supported by data.
🏢 Business Quality: 3/10
📊 Valuation: fair — trailing P/E 14.2x sits below peer average 18.7x but above bear-case 7.4x; negative OCF and high debt justify current multiple, leaving...
🔮 Catalyst: Next quarterly earnings (expected within 6 months)
⚖️ Avoid: 1:1 reward/risk fails threshold, negative operating cash flow is a serious red flag, and no clear catalyst justifies immediate entry.